At the moment, we are focused most heavily on work-related carpal tunnel syndrome (CTS), which is one of the most common workplace-related conditions.
- 13 million Americans suffer from CTS, but only 400,000 undergo surgery annually.1
- Many avoid surgery because of financial fears and uncertain outcomes. Almost 70% of Americans live paycheck to paycheck and can’t afford a long recovery.2
Prolonged suffering leads to sleep disruption, mental health strain and lost employment. Those affected by CTS often delay treatment and live with ongoing pain, with 80% reporting they wake up multiple times a night, worsening anxiety and depression. A Washington State study3 of nearly 9,000 claims found that six years after closure, workers who had carpal tunnel claims were twice as likely to be unemployed, underscoring the long-term impact of untreated or poorly treated cases.
Traditional open, or “mini-open,” carpal tunnel surgeries involve incisions in the palm, which cause extended pain, higher complication risk and longer recovery times. Endoscopic techniques were developed to improve outcomes; however, limited visibility during surgery has resulted in an elevated risk of nerve injury.
Under the traditional system, an injured worker’s care path for CTS is long and fragmented:
- Initial provider visit and bracing
- Medications, then multiple rounds of physical therapy
- Injections offering temporary relief
- Eventually, surgery — followed by post-op physical therapy
This process can last 18 to 31 months, depending on the state, with significant medical and indemnity costs averaging $35,000 per claim.